When to Initiate Disease-Modifying Drugs for Relapsing Remitting Multiple Sclerosis in Adults?

For patients with Relapsing Remitting Multiple Scierosis Beta Interfaerons and Glatiramer Acetate were the first to be licensed for treatment. This review deals with one major question: when to initiate therapy? Through exploring the unique characteristics of the disease and treatement we suggest an...

Descripción completa

Detalles Bibliográficos
Autores principales: Alkhawajah, Mona, Oger, Joel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195775/
https://www.ncbi.nlm.nih.gov/pubmed/22096641
http://dx.doi.org/10.1155/2011/724871

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195775/
https://www.ncbi.nlm.nih.gov/pubmed/22096641
http://dx.doi.org/10.1155/2011/724871

Ejemplares similares